---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-22-000136"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2022-10-20T23:59:59+00:00"
generated_at: "2026-06-23T02:09:10.035003+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics reports Q3 EPS $2.17, adjusted $2.36; raises 2022 guidance on base business growth of 5.1%

## Summary
- Q3 2022 net revenues $2.49B, down 10.4% YoY; base business revenues $2.17B, up 5.1% YoY; COVID-19 testing $316M, down 55.4%.
- Reported diluted EPS $2.17 (down 46.0%); adjusted diluted EPS $2.36 (down 40.4%).
- Full-year 2022 guidance raised: net revenues $9.72B-$9.86B; adjusted EPS $9.75-$9.95 (prior $9.55-$9.95).
- CEO transition: Jim Davis becomes CEO and President on Nov 1; Steve Rusckowski becomes Executive Chairman through March 2023.

## SEC filing metadata
- accession: 0001022079-22-000136
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2022-10-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000136/0001022079-22-000136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000136/dgx-20221020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-22-000136
- JSON: https://secwatch.observer/filing/0001022079-22-000136.json
- Plain text: https://secwatch.observer/filing/0001022079-22-000136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.